Feb 14, 2023 08:32AM
Feb 14, 2023 08:30AM
Jan 9, 2023 04:52AM
Jan 9, 2023 01:00AM
Dec 20, 2022 04:30PM
Dec 19, 2022 08:34AM
Dec 19, 2022 08:30AM Albireo Submits Bylvay® Alagille Syndrome Regulatory Filings to FDA and EMA
Dec 6, 2022 04:30PM
Dec 6, 2022 08:32AM
Dec 6, 2022 08:30AM
Nov 30, 2022 08:30AM
Nov 9, 2022 08:30AM
Nov 8, 2022 04:01PM
Nov 7, 2022 08:30AM Bylvay® (odevixibat) Data Presented at AASLD The Liver Meeting® 2022, Demonstrating Native Liver Survival in Children Across PFIC Types
Nov 3, 2022 08:30AM
Nov 2, 2022 08:30AM
Nov 1, 2022 08:30AM
Oct 31, 2022 08:30AM
Oct 13, 2022 08:33AM
Oct 13, 2022 08:30AM
Oct 12, 2022 08:30AM Albireo to Participate in H.C. Wainwright 3rd Annual Hepatitis B Virus (HBV) Conference
Oct 11, 2022 07:02AM
Oct 11, 2022 07:00AM
Oct 11, 2022 07:00AM
Oct 11, 2022 07:00AM
Oct 5, 2022 08:30AM
Sep 27, 2022 04:30PM
Sep 22, 2022 08:31AM Albireo Pharma (ALBO) Announces $115 Million Royalty Monetization Agreement with Sagard
Sep 22, 2022 08:30AM
Sep 20, 2022 08:00AM
Sep 6, 2022 08:10AM
Sep 6, 2022 08:00AM
Sep 1, 2022 08:00AM
Aug 22, 2022 05:13PM
Aug 15, 2022 04:05PM Albireo Reports Q2 2022 Financial Results and Business Update
Aug 10, 2022 08:33AM
Aug 10, 2022 08:30AM
Aug 3, 2022 08:30AM
Aug 1, 2022 08:30AM
Jul 26, 2022 04:30PM
Jul 6, 2022 08:30AM
Jun 30, 2022 08:00AM Albireo to Present at the William Blair Biotech Focus Conference 2022
Jun 24, 2022 08:30AM
Jun 24, 2022 08:30AM
Jun 23, 2022 08:30AM
Jun 8, 2022 08:30AM
Jun 7, 2022 08:30AM
Jun 2, 2022 04:30PM
May 23, 2022 08:30AM Albireo Presented Data in Cholestatic Liver Diseases at Digestive Disease Week (DDW) 2022
May 19, 2022 04:30PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All